Influence of Statins on the Survival Outcomes of Patients with Diffuse Large B Cell Lymphoma: A Systematic Review and Meta‐Analysis

Y Li, H Zhou, L Zou - International Journal of Clinical Practice, 2022 - Wiley Online Library
Background. Previous studies evaluating the influence of statins on the survival of patients
with diffuse large B cell lymphoma (DLBCL) showed inconsistent results. This systematic …

[HTML][HTML] Antitumor Activity of Simvastatin in Preclinical Models of Mantle Cell Lymphoma

JC Santos, N Profitós-Pelejà, ML Ribeiro, G Roué - Cancers, 2022 - mdpi.com
Simple Summary Mantle cell lymphoma (MCL) is an aggressive subtype of B-cell non-
Hodgkin lymphoma that remains incurable with standard therapy. A promising approach to …

[HTML][HTML] Can statins lessen the burden of virus mediated cancers?

EH Clark, ST Ahmed, E Chang, EY Chiao… - Infectious Agents and …, 2022 - Springer
Background Oncogenic viruses, including hepatitis B virus (HBV), hepatitis C virus (HCV),
human papillomavirus (HPV), Epstein Barr virus (EBV), and Kaposi Sarcoma Herpes virus …

[HTML][HTML] Factors Associated with Discontinuation of Statin Therapy in Patients with Lymphoma Aged 80 Years and Older: A Retrospective Single-Institute Study

S Yamasaki, T Tokunou, T Horiuchi - Drugs-Real World Outcomes, 2022 - Springer
Background There is little evidence to support or negate the benefits of statin therapy for
primary prevention of cardiovascular disease (CVD) in lymphoma patients aged 80 years or …

[HTML][HTML] Дискутабельные вопросы противоопухолевых эффектов статинов при гемобластозах

РН Мустафин - Онкогематология, 2022 - cyberleninka.ru
Противоопухолевое лекарственное лечение гемобластозов всегда учитывает
коморбидный фон пациента. В связи с частой сердечно-сосудистой патологией и …

Disputable questions of statins antitumor effects in hemoblastoses

RN Mustafin - Oncohematology, 2022 - oncohematology.abvpress.ru
Antitumor drug treatment of hemoblastoses always takes into account the patient
comorbidity. Due to the frequent cardiovascular pathology and atherosclerosis, patients …